{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:21:56Z","timestamp":1773922916793,"version":"3.50.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2019.00177","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T04:29:33Z","timestamp":1574828973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Personalized Cardiovascular Regenerative Medicine: Targeting the Extreme Stages of Life"],"prefix":"10.3389","volume":"6","author":[{"given":"Paolo","family":"Madeddu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria Vincenza","family":"Alvino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Santopaolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaia","family":"Spinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","article-title":"Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials","volume":"117","author":"Afzal","year":"2015","journal-title":"Circ Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/eurjhf\/hfp101","article-title":"Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease","volume":"11","author":"Brunskill","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.110.958405","article-title":"Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005","volume":"123","author":"Dolk","year":"2011","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s12013-015-0551-6","article-title":"Congenital heart disease: causes, diagnosis, symptoms, and treatments","volume":"72","author":"Sun","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"B7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpeds.2014.04.055","article-title":"Heart failure in children: etiology and treatment","volume":"165","author":"Rossano","year":"2014","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/clc.20262","article-title":"Epidemiology of heart failure in a tertiary pediatric center","volume":"31","author":"Massin","year":"2008","journal-title":"Clin Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00059-005-2596-6","article-title":"Congestive heart failure in childhood. An epidemiologic study","volume":"30","author":"Sommers","year":"2005","journal-title":"Herz"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1161\/CIR.0000000000000560","article-title":"Evaluation and management of right-sided heart failure: a scientific statement from the american heart association","volume":"137","author":"Konstam","year":"2018","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton","year":"2017","journal-title":"Circ Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e002846","DOI":"10.1161\/JAHA.115.002846","article-title":"Long-term survival of individuals born with congenital heart disease: a systematic review and meta-analysis","volume":"5","author":"Best","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.amjcard.2005.10.065","article-title":"Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery","volume":"97","author":"Norozi","year":"2006","journal-title":"Am J Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.pcsu.2014.01.002","article-title":"When repair is not feasible: prosthesis selection in children and adults with congenital heart disease","volume":"17","author":"Said","year":"2014","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu."},{"key":"B15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0003-4975(02)03767-0","article-title":"Pericardial tissue valves and Gore-Tex conduits as an alternative for right ventricular outflow tract replacement in children","volume":"74","author":"Allen","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jtcvs.2003.06.017","article-title":"Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells","volume":"127","author":"Rieder","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B17","first-page":"567","article-title":"Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves","volume":"16","author":"Tudorache","year":"2007","journal-title":"J Heart Valve Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(08)61598-6","article-title":"Clinical transplantation of a tissue-engineered airway","volume":"372","author":"Macchiarini","year":"2008","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0140-6736(12)60073-7","article-title":"Engineered whole organs and complex tissues","volume":"379","author":"Badylak","year":"2012","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/pr.2011.61","article-title":"Stem cell therapy for cardiac disease","volume":"71","author":"Bernstein","year":"2012","journal-title":"Pediatr Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2217\/fca.12.13","article-title":"Potential for stem cell use in congenital heart disease","volume":"8","author":"Pincott","year":"2012","journal-title":"Future Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/2150135110362092","article-title":"Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease","volume":"1","author":"Scholl","year":"2010","journal-title":"World J Pediatr Congen Heart Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S0003-4975(02)04706-9","article-title":"Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur)","volume":"75","author":"Bertipaglia","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jtcvs.2009.09.057","article-title":"Late-term results of tissue-engineered vascular grafts in humans","volume":"139","author":"Hibino","year":"2010","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00059-010-3355-x","article-title":"Heart valve and myocardial tissue engineering","volume":"35","author":"Cebotari","year":"2010","journal-title":"Herz"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.athoracsur.2011.06.009","article-title":"Ten years of clinical results with a tissue-engineered pulmonary valve","volume":"92","author":"Dohmen","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/CIRCRESAHA.111.256149","article-title":"Steps toward safe cell therapy using induced pluripotent stem cells","volume":"112","author":"Okano","year":"2013","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jcb.22193","article-title":"Cardiac potential of stem cells from whole human umbilical cord tissue","volume":"107","author":"Wu","year":"2009","journal-title":"J Cell Biochem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.exphem.2009.02.003","article-title":"Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells","volume":"37","author":"Chen","year":"2009","journal-title":"Exp Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1517\/14712598.2011.587800","article-title":"The potential of amniotic fluid stem cells for cellular therapy and tissue engineering","volume":"11","author":"Klemmt","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.117.311206","article-title":"Stem cell therapy for hypoplastic left heart syndrome: mechanism, clinical application, and future directions","volume":"123","author":"Bittle","year":"2018","journal-title":"Circ Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2353\/ajpath.2007.060646","article-title":"Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia","volume":"170","author":"Invernici","year":"2007","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/stem.1868","article-title":"Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity","volume":"33","author":"Chen","year":"2015","journal-title":"Stem Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1161\/CIRCRESAHA.108.192138","article-title":"Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling","volume":"104","author":"Barcelos","year":"2009","journal-title":"Circ Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e002043","DOI":"10.1161\/JAHA.115.002043","article-title":"Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease","volume":"4","author":"Avolio","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrcardio.2010.162","article-title":"Cardiovascular drug therapy in the elderly: benefits and challenges","volume":"8","author":"Fleg","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2105\/AJPH.2008.143958","article-title":"Mexican Americans and frailty: findings from the Hispanic established populations epidemiologic studies of the elderly","volume":"99","author":"Ottenbacher","year":"2009","journal-title":"Am J Public Health"},{"key":"B39","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/j.1464-5491.2010.02977.x","article-title":"Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people","volume":"27","author":"Hubbard","year":"2010","journal-title":"Diabet Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/rheumatology\/ket348","article-title":"Long-term mortality in frail elderly subjects with osteoarthritis","volume":"53","author":"Cacciatore","year":"2014","journal-title":"Rheumatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1161\/ATVBAHA.109.200154","article-title":"Diabetes mellitus induces bone marrow microangiopathy","volume":"30","author":"Oikawa","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/ATVBAHA.112.300424","article-title":"Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway","volume":"33","author":"Mangialardi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34(+) progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circul Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/CIRCRESAHA.116.308366","article-title":"Levels of circulating progenitor cells, cardiovascular outcomes and death: a meta-analysis of prospective observational studies","volume":"118","author":"Rigato","year":"2016","journal-title":"Circ Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.111.243386","article-title":"Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use","volume":"110","author":"Fadini","year":"2012","journal-title":"Circul Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.2337\/dc13-2084","article-title":"Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia","volume":"37","author":"Spinetti","year":"2014","journal-title":"Diabetes Care"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1161\/CIRCULATIONAHA.111.089763","article-title":"Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects","volume":"125","author":"Amadesi","year":"2012","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00125-015-3735-0","article-title":"Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes","volume":"58","author":"Dang","year":"2015","journal-title":"Diabetologia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2337\/db13-0894","article-title":"Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1","volume":"63","author":"Albiero","year":"2014","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1474-9726.2010.00642.x","article-title":"At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways","volume":"10","author":"Fadini","year":"2011","journal-title":"Aging Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2337\/db19-0080","article-title":"Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway","volume":"68","author":"Albiero","year":"2019","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.111.300418","article-title":"MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia","volume":"112","author":"Spinetti","year":"2013","journal-title":"Circ Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.952325","article-title":"Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia","volume":"123","author":"Caporali","year":"2011","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","article-title":"Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3583956","DOI":"10.1155\/2016\/3583956","article-title":"Vascular ageing and exercise: focus on cellular reparative processes","volume":"2016","author":"Ross","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10522-006-9008-z","article-title":"Caloric restriction and human longevity: what can we learn from the Okinawans?","volume":"7","author":"Willcox","year":"2006","journal-title":"Biogerontology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0130658","DOI":"10.1371\/journal.pone.0130658","article-title":"Cardioprotective signature of short-term caloric restriction","volume":"10","author":"Noyan","year":"2015","journal-title":"PLoS ONE"},{"key":"B60","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature08980","article-title":"The genetics of ageing","volume":"464","author":"Kenyon","year":"2010","journal-title":"Nature"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T04:29:36Z","timestamp":1574828976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2019.00177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":60,"alternative-id":["10.3389\/fcvm.2019.00177"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2019.00177","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"article-number":"177"}}